These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37356043)

  • 1. Bone Marrow-Derived Mononuclear Cells in the Treatment of Neurological Diseases: Knowns and Unknowns.
    Nguyen QT; Thanh LN; Hoang VT; Phan TTK; Heke M; Hoang DM
    Cell Mol Neurobiol; 2023 Oct; 43(7):3211-3250. PubMed ID: 37356043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice.
    Wang J; Liu X; Lu H; Jiang C; Cui X; Yu L; Fu X; Li Q; Wang J
    Brain Behav Immun; 2015 Mar; 45():98-108. PubMed ID: 25526817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis.
    Wang J; Yu L; Jiang C; Chen M; Ou C; Wang J
    Brain Behav Immun; 2013 Nov; 34():56-66. PubMed ID: 23891963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke.
    Vahidy FS; Rahbar MH; Zhu H; Rowan PJ; Bambhroliya AB; Savitz SI
    Stroke; 2016 Jun; 47(6):1632-9. PubMed ID: 27165959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of Bone Marrow-Derived Mononuclear Cells Contributed to the Reduction of Hypoxic-Ischemic Brain Injury in Neonatal Rats.
    Sato Y; Ueda K; Kondo T; Hattori T; Mikrogeorgiou A; Sugiyama Y; Suzuki T; Yamamoto M; Hirata H; Hirakawa A; Nakanishi K; Tsuji M; Hayakawa M
    Front Neurol; 2018; 9():987. PubMed ID: 30559704
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone Marrow-Derived Mononuclear Cell Transplantation Can Reduce Systemic Inflammation and Endothelial Glycocalyx Damage in Sepsis.
    Matsubara T; Umemura Y; Ogura H; Matsuura H; Ebihara T; Matsumoto H; Yamakawa K; Shimizu K; Okada H; Shimazu T
    Shock; 2021 Aug; 56(2):260-267. PubMed ID: 33337736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Combination of Bone Marrow Nucleated and Mesenchymal Stem Cells in Complete Spinal Cord Injury.
    Katoh S; Dedeepiya VD; Kuroda S; Iwasaki M; Senthilkumar R; Preethy S; Abraham SJK
    Curr Stem Cell Res Ther; 2021; 16(4):385-399. PubMed ID: 33121414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of autologous bone marrow mononuclear cell administration in the treatment of neurologic sequelae in children with spina bifida.
    Nguyen LT; Le HT; Nguyen KT; Bui HT; Nguyen APT; Ngo DV; Hoang DM; Ngo MD
    Stem Cell Res Ther; 2023 Apr; 14(1):115. PubMed ID: 37118832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.
    Du M; Schmull S; Zhang W; Wang C; Lian F; Chen Y; Xue S
    Stem Cells Int; 2016; 2016():4913515. PubMed ID: 27429622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia.
    Moazzami B; Mohammadpour Z; Zabala ZE; Farokhi E; Roohi A; Dolmatova E; Moazzami K
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD008347. PubMed ID: 35802393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium.
    Ryu JH; Kim IK; Cho SW; Cho MC; Hwang KK; Piao H; Piao S; Lim SH; Hong YS; Choi CY; Yoo KJ; Kim BS
    Biomaterials; 2005 Jan; 26(3):319-26. PubMed ID: 15262474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous Bone Marrow Mononuclear Cell Transplantation Delays Progression of Carotid Atherosclerosis in Rabbits.
    Cui K; Ma X; Yu L; Jiang C; Fu C; Fu X; Yu X; Huang Y; Hou S; Si C; Chen Z; Yu J; Wan J; Wang J
    Mol Neurobiol; 2016 Sep; 53(7):4387-96. PubMed ID: 26232064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy.
    Liu X; Fu X; Dai G; Wang X; Zhang Z; Cheng H; Zheng P; An Y
    J Transl Med; 2017 Feb; 15(1):48. PubMed ID: 28235424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow.
    Fujita Y; Ihara M; Ushiki T; Hirai H; Kizaka-Kondoh S; Hiraoka M; Ito H; Takahashi R
    Stroke; 2010 Dec; 41(12):2938-43. PubMed ID: 20947840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of bone repair by implantation of cryopreserved bone marrow-derived mononuclear cells in a rabbit model of steroid-associated osteonecrosis.
    Xie XH; Wang XL; He YX; Liu Z; Sheng H; Zhang G; Qin L
    Arthritis Rheum; 2012 May; 64(5):1562-71. PubMed ID: 22544527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of concentrated fresh mononuclear cells and cultured mesenchymal stem cells from bone marrow for bone regeneration.
    Du F; Wang Q; Ouyang L; Wu H; Yang Z; Fu X; Liu X; Yan L; Cao Y; Xiao R
    Stem Cells Transl Med; 2021 Apr; 10(4):598-609. PubMed ID: 33341102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning with VEGF Enhances Angiogenic and Neuroprotective Effects of Bone Marrow Mononuclear Cell Transplantation in a Rat Model of Chronic Cerebral Hypoperfusion.
    Wang J; Fu X; Yu L; Li N; Wang M; Liu X; Zhang D; Han W; Zhou C; Wang J
    Mol Neurobiol; 2016 Nov; 53(9):6057-6068. PubMed ID: 26530694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients.
    Rosado-de-Castro PH; Schmidt Fda R; Battistella V; Lopes de Souza SA; Gutfilen B; Goldenberg RC; Kasai-Brunswick TH; Vairo L; Silva RM; Wajnberg E; Alvarenga Americano do Brasil PE; Gasparetto EL; Maiolino A; Alves-Leon SV; Andre C; Mendez-Otero R; Rodriguez de Freitas G; Barbosa da Fonseca LM
    Regen Med; 2013 Mar; 8(2):145-55. PubMed ID: 23477395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway.
    Lovell MJ; Yasin M; Lee KL; Cheung KK; Shintani Y; Collino M; Sivarajah A; Leung KY; Takahashi K; Kapoor A; Yaqoob MM; Suzuki K; Lythgoe MF; Martin J; Munroe PB; Thiemermann C; Mathur A
    Atherosclerosis; 2010 Nov; 213(1):67-76. PubMed ID: 20810112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mononuclear cell therapy can attenuate systemic inflammation in rat heatstroke.
    Umemura Y; Ogura H; Matsuura H; Ebihara T; Shimizu K; Shimazu T
    Scand J Trauma Resusc Emerg Med; 2018 Nov; 26(1):97. PubMed ID: 30445981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.